TWD 42.1
(0.24%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.21 Billion TWD | 10.71% |
2022 | 2.9 Billion TWD | 11.67% |
2021 | 2.6 Billion TWD | -24.82% |
2020 | 3.45 Billion TWD | -31.4% |
2019 | 5.04 Billion TWD | -20.67% |
2018 | 6.35 Billion TWD | -5.36% |
2017 | 6.71 Billion TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 3.21 Billion TWD | -0.01% |
2024 Q2 | 4.84 Billion TWD | 50.66% |
2023 Q1 | 2.42 Billion TWD | -16.59% |
2023 FY | 3.21 Billion TWD | 10.71% |
2023 Q4 | 3.21 Billion TWD | 9.8% |
2023 Q3 | 2.92 Billion TWD | -10.84% |
2023 Q2 | 3.28 Billion TWD | 35.59% |
2022 Q4 | 2.9 Billion TWD | 8.03% |
2022 Q3 | 2.68 Billion TWD | -15.93% |
2022 Q2 | 3.19 Billion TWD | 43.32% |
2022 Q1 | 2.23 Billion TWD | -14.21% |
2022 FY | 2.9 Billion TWD | 11.67% |
2021 Q3 | 3.29 Billion TWD | -21.91% |
2021 FY | 2.6 Billion TWD | -24.82% |
2021 Q1 | 3.14 Billion TWD | -9.16% |
2021 Q2 | 4.22 Billion TWD | 34.36% |
2021 Q4 | 2.6 Billion TWD | -21.13% |
2020 FY | 3.45 Billion TWD | -31.4% |
2020 Q1 | - TWD | -100.0% |
2020 Q4 | 3.45 Billion TWD | 0.0% |
2020 Q2 | 4.48 Billion TWD | 0.0% |
2019 Q1 | - TWD | 0.0% |
2019 Q4 | 5.04 Billion TWD | 0.0% |
2019 FY | 5.04 Billion TWD | -20.67% |
2019 Q3 | 5.04 Billion TWD | 0.0% |
2018 FY | 6.35 Billion TWD | -5.36% |
2017 FY | 6.71 Billion TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Farcent Enterprise Co.,Ltd | 591.03 Million TWD | -444.098% |
Mao Bao Inc. | 175.04 Million TWD | -1737.141% |
Taiyen Biotech Co., Ltd. | 1.77 Billion TWD | -81.59% |
Sanitar Co., Ltd. | 656.05 Million TWD | -390.169% |
Chlitina Holding Limited | 3.75 Billion TWD | 14.388% |
Jourdeness Group Limited | 5.77 Billion TWD | 44.343% |
Nan Liu Enterprise Co., Ltd. | 6.88 Billion TWD | 53.274% |
Luo Lih-Fen Holding Co., Ltd. | 493.87 Million TWD | -551.131% |
San Neng Group Holdings Co., Ltd. | 488.94 Million TWD | -557.694% |
KNH Enterprise Co., Ltd. | 4.94 Billion TWD | 34.992% |